Awarded contractNeg Wo CallSuppliesSpain
El objeto del contrato viene determinado por el suministro de los principios activos denominados "DURVALUMAB 500MG/ 10 ML IV" Y"ACALABRUTINIB 100MG ORAL".
1 supplier awarded•2 lots awarded•€194,924 awarded
Buyer: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín / Las Palmas de Gran Canaria, Spain
Published Mar 14, 2024Awarded Feb 04, 2024
Various medicinal products
Awarded value
€194.9K
Estimated value
€194.9K
Awarded at 100% of estimated value
Award date
Feb 04, 2024
Winners
1
Lots awarded
2
Award values
Notice total
€194.9K
Sum of lot awards
€429.5K
TED notice total and lot-level values do not exactly match.
Winners
ASTRAZENECA FARMACEUTICA SPAIN, S.A.
2 lotsMadrid, ESP
€429,495 This contract
14 award notices•18 awarded lots•€8.97M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | ASTRAZENECA FARMACEUTICA SPAIN, S.A. | €234,571 | Various medicinal products (33690000) | |
| LOT-0002 | ASTRAZENECA FARMACEUTICA SPAIN, S.A. | €194,924 | Various medicinal products (33690000) |